Annals of hepatology (1117 documentos)


21.- The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection
Golabi, Pegah1; Otgonsuren, Munkhzul1; Sayiner, Mehmet1; Arsalla, Aimal1; Gogoll, Trevor1; Younossi, Zobair M1
1Inova Health System, Betty and Guy Beatty Center for Integrated Research, Falls Church, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 342-348]
22.- The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review
Kelly, Sean G1; Campbell, Toby C2; Hillman, Luke3; Said, Adnan2; Lucey, Michael R2; Agarwal, Parul D24
1Ohio State University, Columbus, Ohio. Estados Unidos de América; 2University of Wisconsin, Madison, Wisconsin. Estados Unidos de América; 3Northwestern University, Chicago, Illinois. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 395-401]
23.- Transient Elastography vs. Aspartate Aminotransferase to Platelet Ratio Index in Hepatitis C: A Meta-Analysis
Mattos, Angelo Zambam de1; Mattos, Angelo Alves de2
1Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul. Brasil; 2Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Rio Grande do Sul. Brasil
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 349-357]
24.- Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability
Melchor Mendoza, Yazmín Karel1; Martínez Benítez, Braulio1; Mina Hawat, Aline2; Rodríguez Leal, Gustavo2; Duque, Ximena2; Moran Villota, Segundo3
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Patología, Ciudad de México. México; 2Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Ciudad de México. México; 3Fundación Clínica Médica Sur, Ciudad de México. México
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 430-435]
25.- What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There any Place for Surgery?
Perrakis, Aristotelis1; Vassos, Nikolaos1; Grützmann, Robert1; Croner, Roland S1
1University of Erlangen-Nuremberg, Department of Surgery, Erlangen, Baviera. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 333-341]
26.- Age-standardized mortality rates related to cirrhosis in Brazil from 2000 to 2012: A nationwide analysis
Perazzo, Hugo1; Pacheco, Antonio G2; De Boni, Raquel1; Luz, Paula M1; Fittipaldi, Juliana1; Cardoso, Sandra W1; Grinsztejn, Beatriz1; Veloso, Valdilea G1
1Fundacao Instituto Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro. Brasil; 2Fundacao Instituto Oswaldo Cruz, Programa de Computacao Cientifica, Sao Paulo. Brasil
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 269-278]
27.- A new paradigm in gallstones diseases and marked elevation of transaminases: An observational study
Campos, Sara Teles de1; Silva, Nuno2; Carvalho, Armando2
1Centro Hospitalar e Universitario de Coimbra, Departamento de Gastroenterologia, Coimbra. Portugal; 2Centro Hospitalar e Universitario de Coimbra, Departamento de Medicina Interna, Coimbra. Portugal
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 285-290]
28.- Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment
Senín, Alicia1; Broquetas, Teresa2; Lens, Sabela3; Cañete, Nuria2; Londoño, María Carlota3; Ferraro, Mariana1; Forns, Xavier3; Salar, Antonio1; Carrión, Jose A2
1Hospital del Mar, Departamento de Hematología Clínica, Barcelona. España; 2Hospital del Mar, Departamento de Gastroenterología, Barcelona. España; 3Institut d'Investigacions Biomediques August Pi i Sunyer, Hospital Clinic, Barcelona. España
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 312-3]
29.- A randomized controlled trial of procedural techniques for large volume paracentesis
Shriver, Amy R1; Rudnick, Sean R1; Intagliata, Nicolas M1; Wang, Amanda M2; Caldwell, Stephen H1; Northup, Patrick G1
1University of Virginia, Division of Gastroenterology and Hepatology, Charlottesville, Virginia. Estados Unidos de América; 2University of Virginia, School of Medicine, Charlottesville, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 279-284]
30.- Cancer stem cells are depolarized relative to normal stem cells derived from human livers
Bautista, Wendy1; Lipschitz, Jeremy2; McKay, Andrew2; Minuk, Gerald Y1
1University of Manitoba, Department of Medicine, Winnipeg, Manitoba. Canadá; 2University of Manitoba, Department of Surgery, Winnipeg, Manitoba. Canadá
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 297-303]
31.- Clinical impact of portal vein thrombosis prior to liver transplantation: A retrospective cohort study
Karvellas, Constantine J1; Cardoso, Filipe S2; Senzolo, Marco3; Wells, Malcolm4; Alghanem, Mansour G4; Handou, Fayaz1; Kwapisz, Lukasz4; Kneteman, Norman M5; Marotta,Paul J4; Al-Judaibi, Bandar5
1University of Alberta, Division of Gastroenterology, Edmonton, Alberta. Canadá; 2University of Alberta, Division of Critical Care Medicine, Edmonton, Alberta. Canadá; 3Ospedale Universitario di Padova, Padova, Veneto. Italia; 4Western University, London Health Sciences Centre, London, Ontario. Canadá; 5University of Alberta, Division of Surgery, Edmonton, Alberta. Canadá
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 236-246]
32.- Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Rezaee-Zavareh, Mohammad S1; Hesamizadeh, Khashayar1; Behnava, Bita1; Alavian, Seyed M1; Gholami-Fesharaki, Mohammad2; Sharafi, Heidar1
1Baqiyatallah University of Medical Sciences, Teherán. Irán; 2Tarbiat Modares University, Faculty of Medical Sciences, Teherán. Irán
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 188-197]
33.- Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience
Varghese, Joy1; Kumar Kedarisetty, Chandan1; Venkataraman, Jayanthi1; Srinivasan, Vijaya1; Deepashree, Thiruchunapalli1; Chinnappa Uthappa, Mangerira1; Ilankumaran, Kaliamurthy1; Govil, Sanjay1; Srinivas Reddy, Mettu1; Rela, Mohamed1
1Institute of Liver Diseases and Transplantation, Global Health city, Chennai, Tamil Nadu. India
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 247-2]
34.- Drug-induced liver injury caused by Ipragliflozin administration with causality Established by a positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A case report
Niijima, Katsura1; Niijima, Yawara1; Okada, Shuichi2; Yamada, Masanobu2
1Kan-etsu Chuo Hospital, Takasaki, Gunma. Japón; 2Gunma University, Department of Medicine and Molecular Science, Maebashi, Gunma. Japón
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 308-311]
35.- Effect of treatment with direct acting antiviral on glycemic control in patients with diabetes mellitus and chronic hepatitis C
Stine, Jonathan G1; Wynter, Javelle A1; Niccum, Blake1; Kelly, Virginia1; Caldwell, Stephen H1; Shah, Neeral L1
1University of Virginia, School of Medicine, Charlottesville, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 215-220]
36.- Foamy histiocyte-like hepatocellular carcinoma (HCC): A new variant of HCC?
Dunn, Richard1; Zhang, Wei1; Lai, Jenny Z2; Litton, Tyler1; Zhou, Yihua1; Lai, Jin-Ping1
1Saint Louis University, School of Medicine, Saint Louis, Misuri. Estados Unidos de América; 2Washington University in St. Louis, University College, Saint Louis, Misuri. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 304-307]
37.- Hepatitis B and NAFLD: Lives Crossed
Morales, María Luisa1; Sendra, Carmen1; Romero Gómez, Manuel1
1Universidad de Sevilla, Hospital Universitario Virgen Macarena, Sevilla. España
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 185-187]
38.- Hepatitis B Reactivation or Hepatitis C Exacerbation in Patients with Hematological Malignancies
Ruiz, Isaac1; Pawlotsky, Jean-Michel1
1Université Paris-Est, Creteil, Val-de-Marne. Francia
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 179-181]
39.- High prevalence of ITPA alleles associated with ribavirin-induced hemolytic anemia among mexican population
González Aldaco, Karina1; Panduro, Arturo1; Rebello-Pinho, Joao R2; Martínez López, Erika1; Gleyzer, Ketti2; Fierro, Nora A1; Román, Sonia1
1Hospital Civil de Guadalajara Fray Antonio Alcalde, Departamento de Biología Molecular en Medicina, Guadalajara, Jalisco. México; 2Hospital Israelita Albert Einstein, Sao Paulo. Brasil
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 221-229]
40.- Identification of matrix metalloproteinase-2 and 9 as biomarker of intrahepatic cholestasis of pregnancy
Chen, Zhong1; Shen, Zongji2; Hu, Lingqing1; Lu, Mudan1; Feng, Yizhong3
1Nanjing Medical University, Wuxi Maternity, Wuxi, Jiangsu. China; 2Soochow University, First Affiliated Hospital, Suzhou, Jiangsu. China; 3Soochow University, Second Affiliated Hospital, Suzhou, Jiangsu. China
[Annals of hepatology, México, 2017 Vol. 16 Núm. 2 Mar-Abr, Pág. 291-296]